Phenotypic heterogeneity in the gray platelet syndrome extends to the expression of TREM family member, TLT-1

Summary

The Gray platelet syndrome (GPS) is a rare inherited disorder linked to undefined molecular abnormalities that prevent the formation and maturation of α-granules. Here, we report studies on two patients from unrelated families that confirm phenotypic heterogeneity in the disease. First we used immunoelectron microscopy (I-EM) to confirm that TREM-like transcript-1 (TLT-1) is mostly localized to α-granule membranes of normal platelets. Then we performed Western blotting (WB) and flow cytometry with permeabilized platelets to show that TLT - 1 is selectively reduced in the platelets of patient 1, previously noted to be deficient in glycoprotein (GP)VI (Nurden et al., Blood 2004; 104: 107–114).Yet both TLT - 1 and GPVI were normally expressed in platelets of patient 2. Usual levels of JAM-C and claudin-5, also members of the immunoglobulin receptor family, were detected in platelets of both patients. In contrast, P-selectin was markedly decreased for patient 1 but not patient 2.Two metalloproteases, MMP-2 and MMP-9 were normally present. As predicted, platelets of patient 1 showed little labelling for TLT - 1 in I-EM, whereas residual Fg was seen in small vesicular structures and P-selectin lining vacuoles or channels of what may be elements of the surface-connected canalicular system. Our results identify TLT - 1 as a glycoprotein potentially targeted in platelets of GPS patients, while decreases in at least three membrane glycoproteins suggest that an unidentified proteolytic activity may contribute to the phenotype in some patients with this rare disease.

Keywords

Gray platelet syndrome - inherited / acquired platelet disorders - protein trafficking - secretion / exocytosis

• References

• 1 Klesney-Tait J, Turnbull IR, Colonna M. The TREM receptor family and signal integration. Nat Immunol 2006; 07: 1266-1273.
• 2 Washington A V, Schubert RL, Quigley L. et al. A TREM family member, TLT-1, is found exclusively in the α-granules of megakaryocytes and platelets. Blood 2004; 104: 1042-1047.
• 3 Barrow AD, Astoul E, Floto A. et al. Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances rather than inhibits, calcium signaling via SHP-2. J Immunol 2004; 172: 5838-5842.
• 4 Gattis JL, Washington AV, Chisholm MM. et al. The structure of the extracellular domain of triggerin receptor expressed on myeloid cells like transcript-1 and evidence for a naturally occurring soluble fragment. J Biol Chem 2006; 281: 13396-13403.
• 5 Giomarelli B, Washington VA, Chisholm MM. et al. Inhibition of thrombin-induced platelet aggregation using human single-chain Fv antibodies specific for TREM-like transcript-1. Thromb Haemost 2007; 97: 955-963.
• 6 Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007; 21: 31-36.
• 7 Rosa JP, George JN, Bainton DF. et al. Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest 1987; 80: 1138-1146.
• 8 Santoso S, Sachs UJH, Kroll H. et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002; 196: 679-691.
• 9 Chavakis T, Keiper T, Matz-Westphal R. et al. The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. J Biol Chem 2004; 279: 55602-55608.
• 10 Koval M. Claudins - key pieces in the tight junction puzzle. Cell Commun Adhes 2006; 13: 127-138.
• 11 Mori K, Suzuki S, Sugai K. Electron microscopic and functional studies on platelets in gray platelet syndrome. Tohoku J Exp Med 1984; 143: 261-287.
• 12 Nurden P, Jandrot-Perrus M, Combrié R. et al. Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome. Blood 2004; 104: 107-114.
• 13 Israels SJ, Gerrard JM, Jacques YV. et al. Platelet dense granule membranes contain both granulophysin and P-selectin(GMP-140). Blood 1992; 80: 143-152.
• 14 Sarratt KL, Chen H, Zutter MM. et al. GPVI and 0C2P1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood 2005; 106: 1268-1277.
• 15 De Candia E, Pecci A, Ciabattoni G. et al. Defective platelet responsiveness to thrombin and protease-activated receptors in a novel case of gray platelet syndrome: correlation between the platelet defect and the a-granule content in the patient and four relatives. J Thromb Haemost 2007; 05: 551-559.
• 16 Enouf J, Lebret M, Bredoux R. et al. Abnormal calcium transport into microsomes of grey platelet syndrome. Br J Haematol 1987; 65: 437-440.
• 17 Lages B, Sussman II, Levine SP. et al. Platelet a-granule deficiency associated with decreased P-selectin and selective impairment of thrombin-induced activation in a new patient with gray platelet syndrome (oestoragepool deficiency). J Lab ClinMed 1997; 129: 364-377.
• 18 Legrand C, Thibert V, Dubernard V. et al. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation. Blood 1992; 79: 1995-2003.
• 19 Arthur JF, Dunkely S, Andrews RK. Platelet glycoprotein VI-related clinical defects. Br J Haematol 2007; 139: 363-372.
• 20 Boylan B, Chen H, Rathore V. et al. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of GPVI/FcRy-chain complex from the human platelet surface. Blood 2004; 104: 1350-1355.
• 21 Andrews RK, Karunakaran D, Gardiner EE, Berndt MC. Platelet receptor proteolysis : a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007; 27: 1511-1520.
• 22 Gardiner EE, Karunakaran D, Arthur JF. et al. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcyRIIa. Blood 2008; 111: 165-174.
• 23 Galt SW, Lindemann S, Allen L. et al. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res 2002; 90: 1093-1099.
• 24 Sawicki G, Salas E, Murat J. et al. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616-619.
• 25 Sawicki G, Sanders EJ, Salas E. et al. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 1998; 80: 836-839.
• 26 Sheu JR, Fong TH, Liu CM. et al. Expression of matrix metalloprotease-9 in human platelets: regulation of platelet activation in vitro and in vivo studies. Br J Pharmacol 2004; 143: 193-201.
• 27 Santos-Martinez MJ, Medina C, Jurasz P, Radoms-ki MW. Role of metalloproteinases in platelet function. Thromb Res 2008; 121: 535-542.
• 28 Gardiner EE, Karunakaran D, Shen Y. et al. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteases. J Thromb Haemost 2007; 05: 1530-1537.
• 29 Bergmeier W, Piffath CL, Cheng G. et al. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo. Circ Res 2004; 95: 677-683.
• 30 Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 205 280: 14462-468.
• 31 Heijnen HF, Debili N, Vainchenker W. et al. Multivesicular bodies are an intermediate stage in the formation of platelet α-granules. Blood 1998; 91: 2313-2325.
• 32 Disdier M, Morrissey JH, Fugate RD. et al. Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell 1992; 03: 309-321.
• 33 El Golli N, Issertial O, Rosa JP, Briquet-Laugier V. Evidence for a granule targeting sequence within platelet factor 4. J Biol Chem 2005; 280: 30329-30335.
• 34 Harrison PP, Cramer EH. Platelet α-granules. Blood Rev 1993; 07: 52-62.
• 35 Cramer EM, Vainchenker W, Vinci G. et al. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood 1985; 66: 1309-1316.
• 36 Gunay-Ayqun M, Huizing M, Gahl WA. Molecular defects that affect platelet dense granules. Semin Thromb Hemost 2004; 30: 537-547.